- Research works
- 7 ▼ 15% vs 2018-21
- Citations
- 201 29.9 per fractional work
- Top-10% rate
- 38.1% all institutions 10.0%
- Open access
- 56% world 40%
- International
- 36% world 18%
Not ranked overall: IDEA Bio-Medical (Israel) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does IDEA Bio-Medical (Israel) work in?
In all years, 38% of research at IDEA Bio-Medical (Israel) is in Life Sciences, 33% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (36%), Medicine (29%), Environmental Science (11%). It does 1.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 9 fields, with their numbers
- Life Sciences338.0%
- Physical Sciences233.0%
- Environmental Science110.7%
- Chemistry110.0%
- Computer Science07.4%
- Earth and Planetary Sciences03.7%
- Engineering01.2%
- Health Sciences228.8%
- Medicine228.8%
- Social Sciences00.1%
- Decision Sciences00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does IDEA Bio-Medical (Israel) publish most on?
By volume in 2022-now: Zebrafish Biomedical Research Applications, Cell Image Analysis Techniques, Single-cell and spatial transcriptomics and Diet and metabolism studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Zebrafish Biomedical Research Applications Cell Biology 0 works
- 2 Cell Image Analysis Techniques Biophysics 0 works
- 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
- 4 Diet and metabolism studies Physiology 0 works
- 5 Vascular Malformations and Hemangiomas Surgery 0 works
- 6 Islanding Detection in Power Systems Electrical and Electronic Engineering 0 works
- 7 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
- 8 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 9 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
- 10 Indoor Air Quality and Microbial Exposure Health, Toxicology and Mutagenesis 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has IDEA Bio-Medical (Israel)'s research output changed?
Output in 2022-2025 was 15% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is IDEA Bio-Medical (Israel) as a percentage of every work published that year, 0.0000045% in 2024.
Fractional works of IDEA Bio-Medical (Israel) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Rehovot
- Weizmann Institute of Science
- Biokine (Israel)
- Nova Measuring Instruments (Israel)
- Melodea (Israel)
- Elfi-Tech (Israel)
- Vyne Therapeutics (Israel)
- Nucleix (Israel)
- Biomica (Israel)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about IDEA Bio-Medical (Israel). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.